HomeVICO • STO
add
Vicore Pharma Holding AB
Previous close
kr 20.20
Day range
kr 19.70 - kr 21.00
Year range
kr 12.36 - kr 26.90
Market cap
2.20B SEK
Avg Volume
299.32K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 104.24M | — |
Operating expense | 81.08M | 23.80% |
Net income | 31.72M | 147.85% |
Net profit margin | 30.42 | — |
Earnings per share | — | — |
EBITDA | 24.02M | 137.18% |
Effective tax rate | -0.30% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 512.17M | 178.92% |
Total assets | 540.66M | 104.38% |
Total liabilities | 51.83M | 29.75% |
Total equity | 488.83M | — |
Shares outstanding | 113.27M | — |
Price to book | 4.68 | — |
Return on assets | 11.15% | — |
Return on capital | 12.26% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 31.72M | 147.85% |
Cash from operations | 23.08M | 129.71% |
Cash from investing | 70.00M | 1,427.05% |
Cash from financing | — | — |
Net change in cash | 97.55M | 233.30% |
Free cash flow | 9.44M | 117.86% |
About
Founded
2000
Website
Employees
26
